RE:It's all about efficacy % as this what will lead us to a jvSF, I agree with all you said except "we are pretty much head to head", with 803=BCG and CG0070+Keytruda on the low toxicity aspect. I had the opportunity to watch 2 neighbors suffer terribly every 3 weeks after their Keytruda treatments until they passed. Plus I have a very good friend in Maine that underwent 6 weeks of daily(except Sundays), radiation treatments with 1 oncologist and treatments from 2 others(it is believed this cancer was caused by cleaning jets on the decks of aircraft carriers after spraying Agent Orange in Vietnam). His oncologist will not use Keytruda because of it's serious side effects on his patients. I believe this factor alone with entice oncologists to switch to TLT's ACT once approved and available. PS- After I told him about TLT he is now a serious TLT share holder, so is one of his oncologists.